menu
    • menu

    Company profile for Ligand Pharmaceuticals

    NEW Drugs in Dev: 10
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Our business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Our goal is to offer investors an opportunity to participate in th...
    Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Our business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Our goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ligand PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3911, Sorrento Valley Boulevard, Suite 110, San Diego, CA 92121
    Telephone
    Telephone
    +1 858-550-7500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ligand.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ligand-pharmaceuticals
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Ligand_LGND

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ligand To Participate In May Investor Conferences
    Ligand To Participate In May Investor Conferences

    05 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/05/3288207/0/en/ligand-to-participate-in-may-investor-conferences.html

    GLOBENEWSWIRE
    05 May 2026
    Share Share
    Ligand Pharma to Acquire Biotech Royalty Rights Buyer XOMA
    Ligand Pharma to Acquire Biotech Royalty Rights Buyer XOMA

    27 Apr 2026

    // REUTERS

    https://www.reuters.com/legal/transactional/ligand-pharma-buy-fellow-biotech-royalty-rights-buyer-xoma-739-million-2026-04-27/

    REUTERS
    27 Apr 2026
    Share Share
    Ligand Acquires XOMA Royalty, Boosting Profit Growth
    Ligand Acquires XOMA Royalty, Boosting Profit Growth

    27 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/27/3281484/7281/en/ligand-to-acquire-xoma-royalty-further-accelerating-profit-growth-and-strengthening-ligand-s-position-as-a-leading-biopharma-royalty-aggregator.html

    GLOBENEWSWIRE
    27 Apr 2026
    Share Share
    Ligand To Release Q1 2026 Financial Results On May 7
    Ligand To Release Q1 2026 Financial Results On May 7

    22 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/22/3278806/0/en/ligand-to-report-first-quarter-2026-financial-results-on-may-7-2026.html

    GLOBENEWSWIRE
    22 Apr 2026
    Share Share
    Ligand Expands, Strengthens BD Team for Strategic Growth
    Ligand Expands, Strengthens BD Team for Strategic Growth

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3262851/0/en/Ligand-Advances-Strategic-Growth-with-Expanded-and-Strengthened-Business-Development-Team.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    Ligand To Participate In March Investor Conferences
    Ligand To Participate In March Investor Conferences

    04 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/04/3249212/0/en/Ligand-to-Participate-in-March-Investor-Conferences.html

    GLOBENEWSWIRE
    04 Mar 2026
    Share Share

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search